Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 1044Neoplasms 876Prostatic Neoplasms 507Lung Neoplasms 422Colorectal Neoplasms 358Motor Activity 220Head and Neck Neoplasms 194Uterine Cervical Neoplasms 190Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 115Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Depression 93Melanoma 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Interventions

Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Constriction, Pathologic × 1 year × Clear all
NCT05149755 2026-05-19

Evolutâ„¢ EXPAND TAVR II Pivotal Trial

Medtronic Cardiovascular

Phase NA Active not recruiting
650 enrolled
Lymphoid

Constriction, Pathologic, Lymphoma, Follicular

NCT07060183 2025-07-11

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study

Dermed Diagnostics, Inc.

Phase NA Withdrawn
Lymphoid

Constriction, Pathologic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡